Estrogens, Conjugated Synthetic A
drug drugOn this page
Also known as CenestinEstrogensconjugated synthetic aSynthetic conjugated estrogens aSynthetic conjugated estrogensa
Summary
Estrogens, Conjugated Synthetic A (CHEMBL1201466) is an approved unknown; indicated across 2 conditions.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Unknown
- Indications: 2 conditions
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL1201466 |
| Name | Estrogens, Conjugated Synthetic A |
| Type | Unknown |
| Max phase | 4 |
Also known as: Cenestin, Estrogens, conjugated synthetic a, Synthetic conjugated estrogens a, Synthetic conjugated estrogens, a, ESTROGENS, CONJUGATED SYNTHETIC A
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
2 indication records carry no mapped disease name (EFO/MeSH-only); none shown.
Clinical trials
Total trials: 0.
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.